My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Synlogic, Inc. - Common Stock (NQ:SYBX)

0.5600 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Synlogic, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 20, 2023

Via Benzinga

Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket ↗

January 20, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 20, 2023

It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 19, 2023

Via Benzinga

Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year ↗

October 18, 2022

Via Benzinga

Recap: Synlogic Q2 Earnings ↗

August 11, 2022

Synlogic (NASDAQ:SYBX) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Synlogic's Experimental Drug Lowers Urinary Oxalate In Gastric Bypass Patients ↗

December 15, 2022

Synlogic Inc's (NASDAQ: SYBX) SYNB8802 has demonstrated proof of concept through a clinically significant lowering of urinary oxalate in a Phase 1b study in patients with a history of gastric bypass...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 30, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 28, 2022

On Monday, 79 companies reached new 52-week lows.

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Recap: Synlogic Q1 Earnings ↗

May 12, 2022

Synlogic (NASDAQ:SYBX) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

BP To Rally Around 22%? Plus This Analyst Predicts $47 For YETI ↗

November 11, 2022

Piper Sandler boosted the price target on BP p.l.c. (NYSE: BP) from $37 to $40. BP shares rose 1.9% to close at $32.95 on Thursday.

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 23, 2022

Via Benzinga

FDA Grants Fast Track Status To Synlogic's Rare Genetic Disorder Drug ↗

August 23, 2022

Synlogic, Inc. (NASDAQ: SYBX) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its drug candidate SYNB1353 for the potential treatment of homocystinuria...

Via Benzinga

What Is Going on With Ginkgo Bioworks (DNA) Stock Today? ↗

August 12, 2022

DNA stock and other small biotech plays are rising on speculation about drugs like its candidate against gout.

Via InvestorPlace

Why Ginkgo Bioworks Stock Is Soaring Today ↗

August 11, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Thursday after Synlogic Inc (NASDAQ: SYBX) announced a new drug candidate for the treatment of gout, which is being developed in...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

August 01, 2022

On Monday, 92 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 26, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 12, 2022

Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.

Via Benzinga

Synlogic Initiates Initial-Stage Homocystinuria Study ↗

July 12, 2022

Synlogic (NASDAQ: SYBX) has dosed its first healthy volunteer in its Phase 1 study of the investigational oral therapy SYNB1353 for the potential treatment of homocystinuria (HCU).

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 23, 2022

Via Benzinga

22 Stocks Moving in Thursday's Pre-Market Session ↗

June 23, 2022

Gainers WISeKey International Holding AG (NASDAQ: WKEY) rose 74.4% to $2.32 in pre-market trading. WISeKey International recently issued 2022 first-half revenue guidance for its IoT segment.

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Synlogic's Return On Capital Employed Overview ↗

June 16, 2022

Benzinga Pro data, Synlogic (NASDAQ:SYBX) reported Q1 sales of $224.00 thousand. Earnings fell to a loss of $15.70 million, resulting in a 4.03% decrease from last quarter.

Via Benzinga

Synlogic Earnings Preview ↗

May 11, 2022

Synlogic (NASDAQ:SYBX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Synlogic will...

Via Benzinga

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗

May 02, 2022

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...

Via Benzinga

Synlogic's Return On Capital Employed Overview ↗

March 18, 2022

According to data from Benzinga Pro, during Q4, Synlogic's (NASDAQ:SYBX) reported sales totaled $592.00 thousand. Despite a 5.79% increase in earnings, the company posted a loss...

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

March 18, 2022

Keybanc cut the price target on AMETEK, Inc. (NYSE: AME) from $160 to $155. AMETEK shares rose 1% to close at $132.75 on Thursday.

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.